Study summary

In this study several dose levels of ASP3652, given orally for 12 weeks, will be compared with placebo in the treatment of female patients with Bladder Pain Syndrome / Interstitial Cystitis.

Additional Study Details

Phase
2
Product
  • ASP3652
  • Placebo
  • Type
    Interventional
    Masking
    Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
    Enrollment number
    287
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Randomized Study comparing Placebo and ASP3652 in the treatment of women with Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Site: 6301
      Vilnius, Lithuania, 09108
      Completed
      Site: 5302
      Naestved, Denmark, 4700
      Completed
      Site 6202
      Laguna, Tenerife, Spain, 38330
      Completed
      Site 5901
      Porto, Portugal, 4200-319
      Completed
      Site 6002
      Bucharest, Romania, 042122
      Completed
      Site 6203
      Barcelona, Spain, 08024
      Completed
      Site: 5805
      Piaseczno, Poland, 05-500
      Completed
      Site: 6302
      Vilnius, Lithuania, 08661
      Completed
      Site: 5803
      Warsaw, Poland, 02-784
      Completed
      Site: 5402
      Holzminden, Germany, 37603
      Completed
      Site: 5601
      Riga, Latvia, 1002
      Completed
      Site 6101
      Moscow, Russian Federation, 127473
      Completed
      Site: 5603
      Riga, Latvia, 1038
      Completed
      Site 6005
      Iasi, Romania, 700503
      Completed
      Site: 5602
      Liepaja, Latvia, 3401
      Completed
      Site 6006
      Brasov, Romania, 500152
      Completed
      Site: 5802
      Warsaw, Poland, 00-865
      Completed
      Site 5806
      Bydgoszcz, Poland, 85-094
      Completed
      Site: 5203
      Kromeriz, Czech Republic, 767 55
      Completed
      Site 6103
      Moscow, Russian Federation, 105425
      Completed
      Site: 6303
      Vilnius, Lithuania, 10207
      Completed
      Site: 5702
      Winterswijk, Netherlands, 7101 BN
      Completed
      Site: 5409
      Frankfurt am Main, Germany, 60590
      Completed
      Site 6204
      Malaga, Spain, 29009
      Completed
      Site 6108
      Moscow, Russian Federation, 101000
      Withdrawn
      Site 6109
      Moscow, Russian Federation, 123995
      Completed
      Site: 5301
      Herlev, Denmark, 2730
      Completed
      Site: 5303
      Aarhus, Denmark, 8200
      Completed
      Site 5903
      Porto, Portugal, 4099-001
      Completed
      Site: 5801
      Lodz, Poland, 90-447
      Completed
      Site 5902
      Coimbra, Portugal, 3000-075
      Completed
      Site 6004
      Bucharest, Romania, 021392
      Withdrawn
      Site 6107
      Tomsk, Russian Federation, 634063
      Completed
      Site: 5405
      Mainz, Germany, 55131
      Withdrawn
      Site 6104
      Moscow, Russian Federation, 105425
      Completed
      Site 6003
      Bucharest, Romania, 0100-000
      Completed
      Site: 6111
      Moscow, Russian Federation, 115682
      Completed
      Site: 5206
      Olomouc, Czech Republic, 775 20
      Withdrawn
      Site: 5407
      Moenchengladbach, Germany, 41063
      Completed
      Site: 5812
      Poznan, Poland, 61-397
      Completed
      Site: 5406
      Duisburg, Germany, 47179
      Completed
      Site: 5414
      Offenburg, Germany, 77654
      Withdrawn
      Site 6105
      Omsk, Russian Federation, 644013
      Withdrawn
      Site: 5408
      Reutlingen, Germany, 72764
      Completed
      Site: 5202
      Kralove, Czech Republic, 500 05
      Completed
      Site: 5403
      Emmendingen, Germany, 79312
      Completed
      Site: 5811
      Chorzow, Poland, 41-500
      Withdrawn
      Site: 5705
      Gouda, Netherlands, 2803 HH
      Completed
      Site: 5210
      Sternberk, Czech Republic, 785 01
      Completed
      Site: 5209
      Plzen, Czech Republic, 301 00
      Completed
      Site: 5807
      Bialystok, Poland, 15-224
      Withdrawn
      Site 5105
      Brussels, Belgium, 1000
      Withdrawn
      Site: 5104
      Kortrijk, Belgium, 8500
      Completed
      Site: 5703
      Maastricht, Netherlands, 6229 HX
      Completed
      Site: 5704
      Zwijndrecht, Netherlands, 3331 LZ
      Withdrawn
      Site: 5401
      Herne, Germany, 44627
      Completed
      Site 6201
      Barcelona, Spain, 08850
      Completed
      Site: 5103
      Brussels, Belgium, 1070
      Completed
      Site 6007
      Bucharest, Romania, 022328
      Completed
      Site 6001
      Targu Mures, Romania, 540103
      Completed
      Site: 5804
      Warsaw, Poland, 01-432
      Completed
      Site: 5101
      Antwerp, Belgium, 2650
      Withdrawn
      Site: 5207
      Usti nad Labem, Czech Republic, 401 13
      Completed
      Site: 5706
      Amsterdam, Netherlands, 1081HV
      Completed
      Site: 5201
      Uherske Hradiste, Czech Republic, 686 68
      Withdrawn
      Site: 5208
      Jablonec nad Nisou, Czech Republic, 466 60
      Completed
      Site: 5701
      Nijmegen, Netherlands, 6525 GA
      Completed
      Site 6102
      St.-Petersburg, Russian Federation, 197022
      Withdrawn
      Site: 5102
      Gent, Belgium, 9000
      Withdrawn
      Site 6110
      Rostov-on-Don, Russian Federation, 344022
      Completed
      Site 6106
      Moscow, Russian Federation, 117997
      Completed
      Site 5410
      Kirchheim, Germany, 73270
      Completed
      Site: 6304
      Kaunas, Lithuania, 50154
      Completed
      Site: 5404
      Nurtingen, Germany, 72622
      Withdrawn
      Site: 5205
      Praha, Czech Republic, 121 08

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?